NEWS
Cyber vendors or cyber criminals, who will win the AI race?

By Brett Raybould, EMEA Solutions Architect, Menlo Security.

Read More
NEWS
How remote work makes breaches worse

By Ash Patel, General Manager, EMEA - Zimperium.

Read More
NEWS
The Role of Generative AI in Cybersecurity

By Antonio Sanchez, Principal Cybersecurity Evangelist, Fortra.

Read More
NEWS
True Security Starts from the Inside Out

By Emma Lowe, Director International Field Marketing, Virtru.

Read More
NEWS
Why legacy data is a risk and how to address it

By Dirk Schrader, VP of Security Research and Field CISO EMEA at Netwrix.

Read More
NEWS
DevSecOps: Secure infrastructure by design

DevSecOps is an increasingly popular approach to securing critical infrastructure and applications....

Read More
NEWS
All is not what it SIEMS!

Observations from working with Managed Security Services Providers (MSSPs). By Piers Wilson, Head...

Read More

Videos

Neil Fowler, SVP of Hybrid Cloud Engineering at Rocket Software, discusses the challenges and opportunities of IT modernisation, offering some valuable insights as to the essential ingredients of a successful...
News and views from the recent DCA-organised Data Centre Transformation 2024 event.
Barny Evans, Director of Sustainability and ESG at Turley, explains how the data centre industry can sustainably navigate the energy demands of the AI revolution, discussing innovative approaches to powering...
Ciarán Forde, VP, Strategic Accounts & Alliances, Electrical Sector Sales - EMEA, Eaton, discusses the collaboration between Eaton and data centre design and build company CTS Nordics, which has recently seen...

News

Through a new partnership with Infinigate Cloud, Guardz will help to secure SMBs and support the MSP community across EMEA.
Channel partners can now use customised AI assistants, powered by ArrowSphere AI, to reinvent the way they manage business operations and engage with their customers.
NTT DATA research shows organizations shifting from experiments to investments that drive performance.
The promise of AI is on every biopharma’s radar, but the reality today is that much of the industry is grappling with how to convert the hype into impact.